[HTML][HTML] Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection

MS Durstenfeld, MJ Peluso, JD Kelly, S Win… - JCI insight, 2022 - ncbi.nlm.nih.gov
Shortness of breath, chest pain, and palpitations occur as postacute sequelae of COVID-19,
but whether symptoms are associated with echocardiographic abnormalities, cardiac …

Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2

Z Mahmoud, L East, M Gleva, PK Woodard… - International Journal of …, 2022 - Elsevier
Background Acute COVID-19 infection has been shown to have significant effects on the
cardiovascular system. Post-acute sequelae of SARS-CoV-2 (PASC) are being identified in …

[HTML][HTML] Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?

NM Dixit, A Churchill, A Nsair, JJ Hsu - American heart journal plus …, 2021 - Elsevier
Abstract Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms> 3–4
weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from …

[HTML][HTML] Long-term cardiac pathology in individuals with mild initial COVID-19 illness

VO Puntmann, S Martin, A Shchendrygina… - Nature medicine, 2022 - nature.com
Cardiac symptoms are increasingly recognized as late complications of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in previously well individuals …

[HTML][HTML] The majority of severe COVID-19 patients develop anti-cardiac autoantibodies

M Fagyas, B Nagy Jr, AP Ráduly, IS Mányiné, L Mártha… - Geroscience, 2022 - Springer
Severe cases of COVID-19 are characterized by an inflammatory burst, which is
accompanied by multiorgan failure. The elderly population has higher risk for severe or fatal …

[HTML][HTML] Inflammatory and cardiac biomarkers in relation with post-acute COVID-19 and mortality: what we know after successive pandemic waves

C Lionte, V Sorodoc, RE Haliga, C Bologa… - Diagnostics, 2022 - mdpi.com
Background: Biomarkers were correlated with mortality in critically ill COVID-19 patients. No
prediction tools exist for noncritically ill COVID-19 patients. We aimed to compare the …

[HTML][HTML] Cardiac involvement in recovered patients from COVID-19: a preliminary 6-month follow-up study

X Wu, KQ Deng, C Li, Z Yang, H Hu, H Cai… - Frontiers in …, 2021 - frontiersin.org
Background: Accumulating evidence has revealed that coronavirus disease 2019 (COVID-
19) patients may be complicated with myocardial injury during hospitalization. However …

[HTML][HTML] Long-term cardiac sequelae in patients referred into a diagnostic post-COVID-19 pathway: the different impacts on the right and left ventricles

G Pelà, M Goldoni, C Cavalli, F Perrino, S Tagliaferri… - Diagnostics, 2021 - mdpi.com
Most patients who had COVID-19 are still symptomatic after many months post infection, but
the long-term outcomes are not yet well defined. The aim of our prospective/retrospective …

[HTML][HTML] Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19

M Bearse, YP Hung, AJ Krauson, L Bonanno, B Boyraz… - Modern Pathology, 2021 - Elsevier
COVID-19 has been associated with cardiac injury and dysfunction. While both myocardial
inflammatory cell infiltration and myocarditis with myocyte injury have been reported in …

[HTML][HTML] Long-term comprehensive cardiopulmonary phenotyping of COVID-19

LM Kimmig, ZA Rako, S Ziegler, MJ Richter, AT GS… - Respiratory …, 2022 - Springer
Background Persistent symptoms after initial COVID-19 infection are common and are
frequently referred to by the umbrella terms “post-COVID syndrome” and “long COVID”. The …